![](/img/cover-not-exists.png)
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
Olivier Rixe, Waldo Ortuzar, Manuel Alvarez, Ricardo Parker, Eddie Reed, Ken Paull, Tito FojoVolume:
52
Year:
1996
Language:
english
DOI:
10.1016/s0006-2952(97)81490-6
File:
PDF, 1.04 MB
english, 1996